Success Stories: EB-1A Approved for a Research Associate in California in the Field of Molecular Biology
Client’s Testimonial:
Great to hear the news! Thanks for your help and hardworking!
On March 19th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Research Associate in the Field of Molecular Biology (Approval Notice)
Position at the Time of Case Filing: Research Associate
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: March 19th, 2015
Processing Time: 22 days (8 days after Requesting Premium Processing)
In this case, the client that we had the opportunity to work with was a Research Associate from China in the field of molecular biology. She had conducted her research in the highly specialized area of protein channels. Her work had resulted in 12 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that her case was filed, her publications had been cited at least 460 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work. She had also reviewed 31 manuscripts for distinctive, internationally-circulated journals. Her superior level of expertise was confirmed in the following quote from an independent recommender, “To conclude these remarks, I must here reiterate that [Client] is a global leader in the field of biomedical science and cell biology…Her unmatched propensity for extraordinary research in furthering scientific understanding of intracellular signaling yields applicable results for the fields of disease treatment and biomedical science techniques as they apply to cellular resolutions to disease genesis.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of molecular biology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 22 days (8 days after requesting Premium Processing).